Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds

被引:31
作者
Espinel-Ingroff, A.
Fothergill, A.
Ghannoum, M.
Manavathu, E.
Ostrosky-Zeichner, L.
Pfaller, M. A.
Rinaldi, M. G.
Schell, W.
Walsh, T. J.
机构
[1] VCU Med Ctr, Richmond, VA 23298 USA
[2] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
[3] Case Western Reserve Univ, Cleveland, OH 44106 USA
[4] Wayne State Univ, Detroit, MI USA
[5] Univ Texas, Houston Med Sch, Houston, TX USA
[6] Univ Iowa, Coll Med, Iowa City, IA USA
[7] Duke Univ, Durham, NC USA
[8] NCI, Bethesda, MD 20892 USA
关键词
D O I
10.1128/JCM.00399-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The CLSI (formerly NCCLS) M38-A document for antifungal susceptibility testing of filamentous fungi does not describe guidelines for echinocandins. A multicenter study (eight centers) evaluated inter- and intralaboratory reproducibilities of two reading times (24 and 48 h or 48 and 72 h) and two end points (MICs and minimum effective concentrations [MECs]) for evaluating anidulafungin against molds. Anidulafungin MICs (>= 50% inhibition) and MECs (morphological hyphal changes) were determined for seven Aspergillus isolates (four species) and one isolate each of Fusarium moniliforme, Fusarium solani, and Paecilomyces variotii and for two Scedosporium apiospermum isolates. The inter- and intralaboratory reproducibilities of 10 replicate tests performed in each laboratory on 10 different days for each isolate was 100% at 24 h (MECs, <= 0.015 mu g/ml) for six Aspergillus and P. variotii isolates. The reproducibility was 94 to 96.7% at 72 h (MECs, 1 to 8 mu g/ml) for S. apiospermum and 96.7 to 97.5% at 48 h (MICs, >= 32 mu g/ml) for both Fusarium isolates. Introduction of these identified optimum testing conditions for anidulafungin into future versions of the M38 document is warranted.
引用
收藏
页码:2180 / 2182
页数:3
相关论文
共 11 条
[1]  
*CLIN LAB STAND I, 2006, M27SI CLIN LAB STAND
[2]   Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole [J].
Espinel-Ingroff, A ;
Fothergill, A ;
Ghannoum, M ;
Manavathu, E ;
Ostrosky-Zeichner, L ;
Pfaller, M ;
Rinaldi, M ;
Schell, W ;
Walsh, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (10) :5243-5246
[3]   Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991) [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :403-409
[4]   Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.:: NCCLS collaborative evaluation [J].
Espinel-Ingroff, A ;
Bartlett, M ;
Chaturvedi, V ;
Ghannoum, M ;
Hazen, KC ;
Pfaller, MA ;
Rinaldi, M ;
Walsh, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1828-1835
[5]   Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2950-2956
[6]  
Espinel-Ingroff Ana, 2003, Revista Iberoamericana de Micologia, V20, P121
[7]   Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi [J].
EspinelIngroff, A ;
Bartlett, M ;
Bowden, R ;
Chin, NX ;
Cooper, C ;
Fothergill, A ;
McGinnis, MR ;
Menezes, P ;
Messer, SA ;
Nelson, PW ;
Odds, FC ;
Pasarell, L ;
Peter, J ;
Pfaller, MA ;
Rex, JH ;
Rinaldi, MG ;
Shankland, GS ;
Walsh, TJ ;
Weitzman, I .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) :139-143
[8]  
*NAT COMM CLIN LAB, 2001, M23A2 NCCLS
[9]  
National Committee for Clinical Laboratory Standards, 2002, M27A2 NCCLS
[10]   Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species [J].
Odds, FC ;
Motyl, M ;
Andrade, R ;
Bille, J ;
Cantón, E ;
Cuenca-Estrella, M ;
Davidson, A ;
Durussel, C ;
Ellis, D ;
Foraker, E ;
Fothergill, AW ;
Ghannoum, MA ;
Giacobbe, RA ;
Gobernado, M ;
Handke, R ;
Laverdière, M ;
Lee-Yang, W ;
Merz, WG ;
Ostrosky-Zeichner, L ;
Pemán, J ;
Perea, S ;
Perfect, JR ;
Pfaller, MA ;
Proia, L ;
Rex, JH ;
Rinaldi, MG ;
Rodriguez-Tudela, JL ;
Schell, WA ;
Shields, C ;
Sutton, DA ;
Verweij, PE ;
Warnock, DW .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (08) :3475-3482